Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Wolf

Showing results (11-20 of 171) with videos related to

Pageof 18
Sort By:
Autoimmunity|April 25, 2008
Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseasesHans Helmut Niller, Hans Wolf, Janos Minarovits
Analytical Chemistry|September 19, 2002
An aptamer-based quartz crystal protein biosensorMichael Liss, Birgit Petersen, Hans Wolf, et al.
American Journal of Obstetrics and Gynecology|February 19, 2008
Serial hemodynamic measurement in normal pregnancy, preeclampsia, and intrauterine growth restrictionSaskia Rang, Gert A van Montfrans, Hans Wolf
Vaccine|May 2, 2002
Muscle specific versus ubiquitous expression of Gag based HIV-1 DNA vaccines: a comparative analysisAlexandra Bojak, Diana Hammer, Hans Wolf, et al.
Current Opinion in Microbiology|April 6, 2002
Regulation of type III secretion systemsMatthew S Francis, Hans Wolf-Watz, Ake Forsberg
The Biochemical Journal|December 20, 2002
Regulation of transcription by the heterogeneous nuclear ribonucleoprotein E1B-AP5 is mediated by complex formation with the novel bromodomain-containing protein BRD7Julia Kzhyshkowska, Andre Rusch, Hans Wolf, et al.
Vaccine|May 2, 2002
Efficiency of a myogenic DNA vaccine is strictly dependent upon cellular localization of HIV-1 Pr55(gag)Alexandra Bojak, Jens Wild, Hans Wolf, et al.
American Journal of Obstetrics and Gynecology|February 16, 2026
Identification of preterm growth restricted fetuses requiring delivery within 7 daysAndrea Dall'Asta, Tamara Stampalija, Hans Wolf, et al.
The Journal of General Virology|March 26, 2003
The BZLF1 promoter of Epstein-Barr virus is controlled by E box-/HI-motif-binding factors during virus latencyCornelia Thomas, Arnd Dankesreiter, Hans Wolf, et al.
Lakartidningen|November 14, 2009
[Virulence blocking antibiotics. Anti-bacterial agents with completely new action mechanisms]Charlotta Sundin, Mikael Elofsson, Hans Wolf-Watz, et al.
Pageof 18

Showing results (11-20 of 171) with videos related to

Sort By:
Pageof 18
Autoimmunity|April 25, 2008
Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseasesHans Helmut Niller, Hans Wolf, Janos Minarovits
Analytical Chemistry|September 19, 2002
An aptamer-based quartz crystal protein biosensorMichael Liss, Birgit Petersen, Hans Wolf, et al.
American Journal of Obstetrics and Gynecology|February 19, 2008
Serial hemodynamic measurement in normal pregnancy, preeclampsia, and intrauterine growth restrictionSaskia Rang, Gert A van Montfrans, Hans Wolf
Vaccine|May 2, 2002
Muscle specific versus ubiquitous expression of Gag based HIV-1 DNA vaccines: a comparative analysisAlexandra Bojak, Diana Hammer, Hans Wolf, et al.
Current Opinion in Microbiology|April 6, 2002
Regulation of type III secretion systemsMatthew S Francis, Hans Wolf-Watz, Ake Forsberg
The Biochemical Journal|December 20, 2002
Regulation of transcription by the heterogeneous nuclear ribonucleoprotein E1B-AP5 is mediated by complex formation with the novel bromodomain-containing protein BRD7Julia Kzhyshkowska, Andre Rusch, Hans Wolf, et al.
Vaccine|May 2, 2002
Efficiency of a myogenic DNA vaccine is strictly dependent upon cellular localization of HIV-1 Pr55(gag)Alexandra Bojak, Jens Wild, Hans Wolf, et al.
American Journal of Obstetrics and Gynecology|February 16, 2026
Identification of preterm growth restricted fetuses requiring delivery within 7 daysAndrea Dall'Asta, Tamara Stampalija, Hans Wolf, et al.
The Journal of General Virology|March 26, 2003
The BZLF1 promoter of Epstein-Barr virus is controlled by E box-/HI-motif-binding factors during virus latencyCornelia Thomas, Arnd Dankesreiter, Hans Wolf, et al.
Lakartidningen|November 14, 2009
[Virulence blocking antibiotics. Anti-bacterial agents with completely new action mechanisms]Charlotta Sundin, Mikael Elofsson, Hans Wolf-Watz, et al.
Pageof 18